EAMA Sarcopenia in Acute Care Patients in 9+European Countries

Sarcopenia in Acute Care Patients: Protocol for the European Collaboration of Geriatric Surveys: Sarcopenia 9+ European Academy for Medicine of Ageing (EAMA) Project

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04039620

Acronym

EAMA9+

Enrollment

366

Registered

2019-07-31

Start date

2019-03-06

Completion date

2023-04-02

Last updated

2023-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition, Sarcopenia

Keywords

Sarcopenia, Malnutrition, EWGSOP2, Older people, Acute care, Hospitalized

Brief summary

This collaborative study in 9 geriatrics units across Europe aims to apply emerging research to clinical practice, following the Action-Research Philosophy (11). The overall goal is to improve care in patients with - and help prevent - sarcopenia. Understanding the frequency of and risk factors for developing sarcopenia in an acute hospital setting, may help shed light on potential interventions and thus inform the development of future therapeutic strategies. It involves crucial implications for research, clinical practice, and policy towards optimal aging.

Detailed description

Background: Sarcopenia is a nutrition-related disease leading to physical impairment and adverse clinical outcomes. Data regarding its characteristics in hospitalized patients are limited. Aim: This study will assess in older patients admitted to acute medical wards, the prevalence, incidence, and risk factors for development of sarcopenia, or alteration in its severity, and evaluate associated clinical adverse outcomes. Methods: This collaboratively-designed, longitudinal prospective observational study will be carried out in patients aged \>70 admitted to acute geriatric units in 9 European centers. The new sarcopenia diagnostic criteria of the European Working Group on Sarcopenia 2 (EWGSOP2) will be tested at admission and discharge, using isometric handgrip dynamometry, gait speed, and, pragmatically, calf circumference. There will be 3- and 12-month telephone follow-up (including the SARC-F questionnaire). Discussion: Our study will be the first collaboration to assess the prevalence and incidence of sarcopenia (EWGSOP2) and its risk factors in hospitalized patients across Europe.

Interventions

OTHERObservational study, no interventions expected

No interventions are planned

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients aged \>70 admitted to acute hospital medical units

Exclusion criteria

* Length of hospital stay anticipated to be \<24 hours * Hip/lower limb fractures * Major amputations of the lower leg * Terminally ill patients admitted for palliative care

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of sarcopenia as defined by the European consensus on definition and diagnosis (EWGSOP2)	One year (March 2019-March 2020)	Prevalence sarcopenia in acute hospitalized older patients.
Incidence of sarcopenia as defined by the European consensus on definition and diagnosis (EWGSOP2)	One year (March 2019-March 2020)	Incidence of sarcopenia in acute hospitalized older patients.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026